ESCO ASTER PTE LTD is a leading brand in the field of cGMP CRDMO (Contract Development and Manufacturing Organization) globally. They specialize in adherent bioprocessing/continuous processing using flow chemistry, offering a range of products and services to accelerate the discovery to delivery process of various therapeutics. The brand focuses on vaccine, bio, cell, and gene therapy development manufacturing services.

They utilize their proprietary Adherent Tide Motion Platform, supplemented by single-use suspension and fermentation, downstream bioprocessing, and custom bioengineering equipment. In the diagnostic space, they develop mAb-based antigens, single-domain antibodies, and RT PCR reagents. ESCO ASTER also excels in converting batch processes into continuous flow chemistry and offers a range of safety and efficacy testing services in the chem-biopolymer-cosmetic segments.

They are actively involved in addressing the COVID-19 pandemic by developing trace, test, and treat platforms, including diagnostics, therapeutics, and vaccines. With a strong commitment to One Health and sustainability, ESCO ASTER aims to ensure the well-being of animals, humans, and the environment through vaccination and reducing antibiotic dependence. By providing innovative solutions and adhering to the highest quality standards, ESCO ASTER PTE LTD is paving the way for the future of healthcare and bioprocessing